The functional activity of EVI1 in NPC cells was subsequently examined by loss-of-function (using EVI1 siRNA) and gain-of-function (overexpression using pEFzeo-EVI1 vector) studies. The gene discussed is MECOM; the disease is nasopharyngeal carcinoma.